Biberstein Kathryn L

Avg. Two Year Performance

No purchase track record
(28%) Avg. Sale Return
(13%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)(2%)(3%)(15%)(28%)
Sale Success Rate5 of 124 of 124 of 126 of 127 of 12
Drugs » Drug Delivery

EVP/CAO/CCO/CRO Alks Inc;:

Holdings: 182.07K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

SVP, General Counsel:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--